Itron (NASDAQ:ITRI) SVP Sells $19,758.00 in Stock

Key Points

• Itron SVP Christopher Ware sold 200 shares at an average price of $98.79, totaling $19,758, to cover tax withholding on vested equity awards. He retained 29,916 shares.
• Itron’s latest quarter beat earnings expectations, reporting EPS of $1.59 versus the $1.29 consensus, although revenue fell 7.2% year over year to $562.9 million. The company guided for full-year 2026 EPS of $6.30–$6.50.
• Analysts remain broadly positive, with a “Moderate Buy” consensus and an average price target of $131.33 versus the stock’s recent price near $98.73. Institutional investors own 96.19% of Itron’s shares.

Itron, Inc. (NASDAQ:ITRI - Get Free Report) SVP Christopher Ware sold 200 shares of the business's stock in a transaction that occurred on Monday, August 24th. The stock was sold at an average price of $98.79, for a total value of $19,758.00. Following the completion of the sale, the senior vice president owned 29,916 shares of the company's stock, valued at approximately $2,955,401.64. This trade represents a 0.66% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Itron Stock Performance

Itron stock traded up $0.04 during trading hours on Tuesday, reaching $98.73. 594,864 shares of the company were exchanged, compared to its average volume of 879,926. Itron, Inc. has a 12 month low of $77.77 and a 12 month high of $142.00. The company has a current ratio of 2.75, a quick ratio of 2.29 and a debt-to-equity ratio of 0.96. The stock has a 50-day moving average of $90.88 and a 200 day moving average of $90.09. The firm has a market cap of $4.32 billion, a price-to-earnings ratio of 16.48, a PEG ratio of 1.20 and a beta of 1.30.

Itron (NASDAQ:ITRI - Get Free Report) last released its quarterly earnings results on Tuesday, July 28th. The scientific and technical instruments company reported $1.59 EPS for the quarter, beating analysts' consensus estimates of $1.29 by $0.30. Itron had a net margin of 11.90% and a return on equity of 19.26%. The company had revenue of $562.90 million for the quarter, compared to analyst estimates of $566.34 million. During the same quarter last year, the firm posted $1.62 earnings per share. The company's quarterly revenue was down 7.2% compared to the same quarter last year. Itron has set its Q3 2026 guidance at 1.500-1.600 EPS and its FY 2026 guidance at 6.300-6.500 EPS. As a group, research analysts anticipate that Itron, Inc. will post 6.4 earnings per share for the current year.

Analysts Set New Price Targets

Several research firms recently weighed in on ITRI. Roth Capital reissued a "buy" rating and set a $136.00 price objective on shares of Itron in a research report on Wednesday, April 29th. TD Cowen cut their price target on Itron from $145.00 to $130.00 and set a "buy" rating for the company in a report on Wednesday, April 29th. Stephens reissued an "overweight" rating and issued a $130.00 price objective on shares of Itron in a research report on Wednesday, May 20th. Needham & Company LLC boosted their target price on shares of Itron from $116.00 to $128.00 and gave the stock a "buy" rating in a research report on Wednesday, July 29th. Finally, Weiss Ratings reissued a "hold (c)" rating on shares of Itron in a report on Wednesday, August 5th. Eight equities research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, Itron presently has an average rating of "Moderate Buy" and a consensus price target of $131.33.

More Itron News

Here are the key news stories impacting Itron this week:

• Positive Sentiment: Wall Street remains broadly optimistic. Itron has a “Moderate Buy” consensus rating from eight Buy, four Hold and one Sell recommendation, with an average price target of $131.33—well above recent trading levels. Needham raised its target to $128, while Seaport Research Partners set a $150 target. Itron analyst ratings
• Positive Sentiment: Itron’s latest quarterly results exceeded expectations on earnings, reporting $1.59 per share versus the $1.29 consensus estimate. Management also guided for third-quarter 2026 EPS of $1.50–$1.60 and full-year EPS of $6.30–$6.50. Itron earnings and guidance
• Neutral Sentiment: Institutional ownership is high at 96.19%, and several large funds recently increased or initiated positions. That suggests continued institutional interest, although ownership changes do not necessarily indicate near-term buying pressure. Itron institutional ownership
• Negative Sentiment: CFO Joan S. Hooper sold 4,406 shares worth approximately $435,577, while several senior vice presidents and the chief accounting officer collectively sold 1,213 additional shares. The concentration of sales can weigh on sentiment, even though the executives retained substantial positions and identified tax withholding—not an open-market bearish bet—as the reason for the transactions. SEC insider transaction filing
• Negative Sentiment: Revenue in the latest quarter declined 7.2% year over year to $562.9 million, slightly below analyst expectations. This contraction may temper enthusiasm despite the earnings beat and current-year guidance. Itron quarterly results

Institutional Investors Weigh In On Itron

Institutional investors and hedge funds have recently bought and sold shares of the business. California State Teachers Retirement System raised its stake in shares of Itron by 7,889.6% in the 2nd quarter. California State Teachers Retirement System now owns 4,397,628 shares of the scientific and technical instruments company's stock valued at $380,527,000 after buying an additional 4,342,586 shares in the last quarter. Dimensional Fund Advisors LP increased its stake in Itron by 20.9% in the first quarter. Dimensional Fund Advisors LP now owns 1,536,081 shares of the scientific and technical instruments company's stock valued at $137,659,000 after acquiring an additional 265,039 shares during the period. Geode Capital Management LLC increased its stake in Itron by 0.6% in the fourth quarter. Geode Capital Management LLC now owns 1,144,982 shares of the scientific and technical instruments company's stock valued at $106,340,000 after acquiring an additional 6,598 shares during the period. First Trust Advisors LP raised its position in Itron by 22.2% in the first quarter. First Trust Advisors LP now owns 969,228 shares of the scientific and technical instruments company's stock worth $86,872,000 after purchasing an additional 176,053 shares in the last quarter. Finally, Norges Bank acquired a new position in Itron in the fourth quarter worth about $63,990,000. Institutional investors own 96.19% of the company's stock.

About Itron

Itron, Inc NASDAQ: ITRI is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company's offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron's product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source